3 Overlooked Biotechs That Deserve More Attention

With hundreds of biotech stocks on the market, who can keep up with them all? Probably no one. What happens as a result is that usually only the biggest biotechs (or the small biotechs getting bought by the biggest biotechs) get a lot of coverage. But sometimes those aren't the stocks to watch most closely.

You might not have heard too much about Akebia Therapeutics, BioMarin Pharmaceutical, and Idera Pharmaceuticals. These are three biotech stocks that you could be overlooking -- but deserve your attention. Here's why.

Back to news